Navigation Links
Claimsnet.com Reports Fiscal Year 2007 Results
Date:2/26/2008

Including a 13% Growth in Revenue for the Year

DALLAS, Feb. 26 /PRNewswire-FirstCall/ -- Claimsnet.com (OTC Bulletin Board: CLAI), a leading provider of Internet-based business-to-business solutions for the healthcare industry, today reported its results for fiscal year 2007 and fourth quarter of 2007, which ended December 31, 2007.

For the year ended December 31, 2007, the Company reported revenues of $1,648,000, a 13% increase from the $1,464,000 reported for fiscal 2006.

Cost of revenues for the 2007 fiscal year were $1,156,000 compared to $944,000 for the 2006 fiscal year, a 22% increase. Selling, general and administrative expenses of $840,000 were reported for 2007 compared to the $844,000 reported in fiscal 2006.

The Company reported a gross profit of $492,000 for fiscal year 2007, compared with a gross profit of $520,000 for fiscal year 2006, representing a 5% decrease. The loss from operations for fiscal 2007 was $348,000 compared to $324,000 reported in fiscal 2006. The net loss for fiscal year 2007 was $457,000, or $0.02 per share, compared to $389,000, or $0.01 per share, in the prior year.

For the three months ended December 31, 2007, the Company reported revenues of $408,000 compared to revenues of $410,000 reported for the fourth quarter of fiscal year 2006.

Cost of revenues increased 22% to $310,000 for the fourth quarter of 2007 from $254,000 for the fourth quarter of 2006. Selling, general and administrative expenses of $245,000 for the fourth quarter of 2007 increased from the $242,000 reported for the fourth quarter of 2006.

The Company reported a quarterly gross profit in the fourth quarter of 2007 totaling $98,000 compared with a gross profit of $156,000 in the fourth quarter of 2006. The fourth quarter loss from operations was $148,000 compared to the loss of $86,000 reported in the fourth quarter of 2006. The net loss for the quarter was $182,000, or $0.00 per share, as compar
'/>"/>

SOURCE Claimsnet.com
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Unilens Vision Reports 70% Increase in Second Quarter Earnings on Higher Sales and Record Royalty Income
2. Caliper Life Sciences Reports Fourth Quarter and Full Year 2007 Results
3. 012 Smile.Communications Reports Financial Results for Q4 and Full Year 2007
4. HealthSouth Reports Results for Fourth Quarter Ended December 31, 2007
5. NHP Reports Fourth Quarter and Full Year 2007 Earnings
6. High Calcium Intake May Not Help Prevent Fractures, Reports The Harvard Health Letter
7. Clarity for Consumers on Botox Complication and Death Reports
8. Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives
9. Emageon Reports Fourth Quarter and 2007 Financial Results
10. Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program
11. Platinum Underwriters Holdings, Ltd. Reports Record Fourth Quarter and Year Ended December 31, 2007 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...Dec. 4 The National Cancer Institu...ract to Fred Hutchinson Cancer Research Center to ...formation Service Contact Center. ,, The move w...nearly tripling the size of its current CIS workfo...ional, which is scheduled for March 15, 2010. The ...
(Date:12/4/2009)...09 -- Substantial progress has been made over the ...y to diagnose and treat epilepsy and its complicat...s not reached most of the 50 million people around...lion people in the United States who have the diso...president of the American Epilepsy Society (AES), ...
(Date:12/4/2009)... Bobby Berk Home & Author and Political Analy...l Toy Drive benefiting Providence Hospital’s...m. The goal is to raise $5000 in cash and toy dona..., Bobby Berk Home will match the donation. Toys wi...9th at Providence Hospital. , ...
(Date:12/4/2009)...t clear enough to recommend its use, experts say ,... Cancer patients, glaucoma patients and others can...lysis shows that it can help multiple sclerosis (M...t are the hallmark of the debilitating autoimmune ...inoids in MS appears to be comprehensive, and shou...
(Date:12/4/2009)...Y, Calif., Dec. 4 Genomi...at the company will present results from five stud...ymposium (SABCS), taking place December 9-13, 2009...r of the studies analyze Onco type DX®, the ...ns currently use to predict the likelihood of chem...
Breaking Medicine News(10 mins):Health News:Hutchinson Center Wins $55.4 Million Contract to Become Sole Operator of the NCI Cancer Information Service 2Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 2Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 3Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 4Health News:Bobby Berk Home and Leslie Sanchez Announce 1st Annual Toy Drive for DC's Neediest Families 2Health News:Review Finds Marijuana May Help MS Patients 2Health News:Review Finds Marijuana May Help MS Patients 3Health News:Genomic Health to Present Five New Studies at 32nd Annual San Antonio Breast Cancer Symposium 2Health News:Genomic Health to Present Five New Studies at 32nd Annual San Antonio Breast Cancer Symposium 3Health News:Genomic Health to Present Five New Studies at 32nd Annual San Antonio Breast Cancer Symposium 4
... CLEVELAND--A dart-like molecule that sticks to pr...ecked growth of blood vessels, according to resea...Cleveland Clinic Cole Eye Institute. //Uncontrolle...eople over 65 in the United States. Robert Sa...
... Johns Hopkins Kimmel Cancer Center scientists hav...r breast and colon cancers. Their report, publishe...ss,// identifies close to 200 mutated genes, now l...quencing the human genome laid the groundwork for ...
... A gene that has the potential to suppress tumor g...to three separate studies. The gene p16INK4a cause...younger cells.// These older cells seemed to know ...l schools at the University of North Carolina at C...
... A Virginia Tech researcher Stefan Duma has been n...evelopers for his biomechanics innovations.// ...rofessor of mechanical engineering and founding di...editors of Technology Review, a publication of the...
... Two bacterial muscle infections have been found t...emergence of community-acquired methicillin-resist...o researchers in Houston, Texas whose study was pu...d on the skin or in the nose of a quarter to a thi...
... Modern life has risk and uncertainty as a part of...n aeroplanes, a new generation of nuclear power st...belief in the authorities. The government has to d...logic, particularly, when the apparent risk is rel...
Other Medicine News:Health News:Molecule responsible for age associated macular degeneration identified 2Health News:Genome Code Cracked for Breast and Colon Cancers 2Health News:Genome Code Cracked for Breast and Colon Cancers 3Health News:Gene May Regulate Cellular Aging 2Health News:Gene May Regulate Cellular Aging 3Health News:A young scientist recognized for biomechanics innovations 2Health News:A young scientist recognized for biomechanics innovations 3Health News:MRSA Linked with Rise in Bacterial Infections 2Health News:Danger and insecurity in contemporary life 2
(Date:12/3/2009)... Calif. and STATE COLLEGE, Pa., Dec. 3 /PRNewswire...ed the signing of an agreement to provide extended...cs, NextGENe software for next-generation sequenci...ttp://www.newscom.com/cgi-bin/prnh/20090428/LA0674...id, "Our team at Ambry has been providing genomics...
(Date:12/3/2009)...alif., Dec. 3 Pharmacycl...mpany focused on developing and commercializing in... immune mediated diseases and cancer, today announ...l on, Tuesday, December 8, 2009 at 11:00am Eastern...e) to discuss clinical data regarding its HDAC Pro...
(Date:12/3/2009)...c. 3 BioMed Realty Trust...entered into a new lease with Regeneron Pharmaceut...,000 square feet of additional, newly-constructed ...tview campus in Tarrytown, New York. The new lease...l space was completed approximately two months aft...
Breaking Medicine Technology:Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 2BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 3How to execute dietary management in eating disorder patients 61699 1How to execute dietary management in eating disorder patients 61699 2Elsevier celebrates the 20th anniversary of the UN Convention for the Rights of the Child 61697 1Elsevier celebrates the 20th anniversary of the UN Convention for the Rights of the Child 61697 2The benefits of stress in plants 10805 1The benefits of stress in plants 10805 2
...netic and safety data observed in first clinical ...agent -, CAMBRIDGE, Mass., Oct. 24 Mersana, a ca...ts of a Phase I study of its,lead product candidat...s.,The data was presented by Edward A. Sausville, ...rector for Clinical Research, University of,Maryla...
...imacy and Safety of ,First Generation, Antisense, ...ed (Nasdaq: GNTA ) announced the presentation of ...ium) Injection, its lead anticancer,compound, can ...travenous,(IV) infusion. The new data were present...search, South Texas Accelerated Research Therapeut...
Other Medicine Technology:Mersana Therapeutics Reports Phase I Results for XMT-1001 in Patients with Solid Tumors at AACR-NCI-EORTC International Conference 2Mersana Therapeutics Reports Phase I Results for XMT-1001 in Patients with Solid Tumors at AACR-NCI-EORTC International Conference 3Genasense(R) Can be Administered by Brief High-Dose IV Infusion 2Genasense(R) Can be Administered by Brief High-Dose IV Infusion 3Genasense(R) Can be Administered by Brief High-Dose IV Infusion 4
Optiray®
... contrast medium for intravascular and body cavity... of clinical experience and use in over 3.5 millio...able part of the team effort in hundreds of radiol...itoring trials1-3 confirm that IMAGOPAQUE is a wel...
...ontrast medium for Magnetic Resonance Imaging (MRI...r intravenous injection. In MRI, ProHance® pr...d surrounding tissues resulting in improved visual...with abnormal vascularity or those thought to caus...
...ides) is Advanced Magnetics' contrast agent for us...is the first organ-specific MRI contrast agent to ... function, the agent is taken up by macrophages fo...mors. The liver is a principal site for metastasis...
Medicine Products: